Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid.
AHA today urged the FTC to scrutinize commercial health plans that steer patients to third-party specialty pharmacies in which they have a financial interest.
The update includes a button to help beneficiaries prepare to renew their coverage when the COVID-19 public health emergency ends.
U.S. births rose 1% in 2021 to about 3.7 million, the first increase since 2014.
The latest report contains many of the same flaws as last year’s report, says Aaron Wesolowski, AHA vice president of policy research, analytics and strategy.
Surgeon General Vivek Murthy, M.D., today issued an advisory recommending a whole-of-society approach to addressing health worker burnout.
Pfizer’s COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial.
A Senate committee last week held a hearing on how to strengthen cybersecurity in the health care and education sectors.
AHA Friday joined the Chamber of Commerce and Association of American Medical Colleges in a friend-of-the-court brief asking the U.S. District Court for the District of Massachusetts to dismiss the case.
The FDA Tuesday authorized a single booster dose for children in this age group.